RecoverLINK Technology Pilot for HF Patients

Pilot to Assess Feasibility of Using RecoverLINK Technology to Supplement Outpatient Care for Heart Failure Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02815085

Enrollment

Registered

2016-06-28

Start date

2016-02-29

Completion date

2018-06-30

Last updated

2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, mHealth

Brief summary

The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.

Interventions

OTHERRecoverLINK technology

HF patients will receive the RecoverLINK app upon study enrollment for 30-days. The Mount Sinai HF care team will interact with patients via the RecoverLINK cloud-based system during this period

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Heart failure (HF) patients with a rapid follow up appointment scheduled at the Mount Sinai HF clinic * English-speaking * With either access to (i) an iOS smart device or (ii) wifi at-home

Exclusion criteria

Patients meeting any of the following criteria: * A heart transplant * A mechanical circulatory support (MCS) device * An altered mental status * Serious co-morbidities (as identified by Mount Sinai team) * Cognitive impairments (as identified by Mount Sinai team) * Inability to use technology (as identified by Mount Sinai team)

Design outcomes

Primary

Measure	Time frame
User engagement: # symptom surveys completed/30 days	30 days
User satisfaction: Percent patients report satisfied via post-program survey	30 days
Workflow efficiency: mean/median time to resolution of patient alerts	30 days

Secondary

Measure	Time frame
Mean difference in pre/post SCHIFI score	30 days
Hospital admission	30, 60, 90 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026